Cite
APA Citation
Lipton, A., Fizazi, K., Stopeck, A., Henry, D., Smith, M., Shore, N., Martin, M., Vadhan-Raj, S., Brown, J., Richardson, G., Saad, F., Yardley, D., Zhou, K., Balakumaran, A., & Braun, A. (2016). effect of denosumab versus zoledronic acid in preventing skeletal-related events in patients with bone metastases by baseline characteristics. European journal of cancer, 53, 75–83. http://access.bl.uk/ark:/81055/vdc_100030956954.0x000003